Connect Biopharma Holdings Stock Price on November 18, 2024
| CNTB Stock | USD 1.00 0.01 1.01% |
If you're considering investing in Connect Stock, it is important to understand the factors that can impact its price. As of today, the current price of Connect Biopharma stands at 1.00, as last reported on the 23rd of November, with the highest price reaching 1.04 and the lowest price hitting 0.99 during the day. Connect Biopharma appears to be dangerous, given 3 months investment horizon. Connect Biopharma secures Sharpe Ratio (or Efficiency) of 0.0298, which signifies that the company had a 0.0298% return per unit of risk over the last 3 months. We have found thirty technical indicators for Connect Biopharma Holdings, which you can use to evaluate the volatility of the firm. Please makes use of Connect Biopharma's Downside Deviation of 5.8, risk adjusted performance of 0.033, and Mean Deviation of 4.62 to double-check if our risk estimates are consistent with your expectations.
At present, Connect Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 10.1 K, whereas Common Stock Shares Outstanding is forecasted to decline to about 43.5 M. . At present, Connect Biopharma's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price Earnings Ratio is forecasted to decline to (1.15). Connect Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Connect |
Sharpe Ratio = 0.0298
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CNTB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.29 actual daily | 64 64% of assets are less volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Connect Biopharma is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Connect Biopharma by adding it to a well-diversified portfolio.
Price Book 0.5001 | Enterprise Value Ebitda 0.1857 | Price Sales 2.2912 | Shares Float 14.8 M | Wall Street Target Price 7 |
Connect Biopharma Main Headline on 18th of November 2024
US Penny Stocks To Monitor In November 2024 by simplywall.st
As of mid-November 2024, the U.S. stock market has experienced a downturn, with major indexes recording weekly losses due to challenges faced by big-tech companies and concerns over interest rate policies. For investors willing to explore beyond the well-known giants, penny stocksoften representing smaller or newer enterprisescan still offer intriguing prospects. Despite being considered a somewhat outdated term, these stocks remain relevant for those seeking growth opportunities in...
Connect Biopharma Valuation on November 18, 2024
It is possible to determine the worth of Connect Biopharma on a given historical date. On November 18, 2024 Connect was worth 1.11 at the beginning of the trading date compared to the closed value of 1.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Connect Biopharma stock. Still, in general, we apply an absolute valuation method to find Connect Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Connect Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Connect Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 1.05 | 1.11 | 0.98 | 1.11 | 34,063 | |
11/18/2024 | 1.11 | 1.11 | 0.98 | 1.01 | 21,259 |
| 1.02 | 1.02 | 0.95 | 0.98 | 27,413 |
| Backtest Connect Biopharma | | | Connect Biopharma History | | | Connect Biopharma Valuation | Previous | Next |
Connect Biopharma Trading Date Momentum on November 18, 2024
| On November 19 2024 Connect Biopharma Holdings was traded for 0.98 at the closing time. The top price for the day was 1.02 and the lowest listed price was 0.95 . The trading volume for the day was 27.4 K. The trading history from November 19, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.97% . The overall trading delta against the current closing price is 2.97% . |
Connect Biopharma Fundamentals Correlations and Trends
By evaluating Connect Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Connect Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Connect financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Connect Biopharma Stock history
Connect Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Connect is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Connect Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Connect Biopharma stock prices may prove useful in developing a viable investing in Connect Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 55.1 M | 43.5 M | |
| Net Loss | -1.2 B | -1.1 B |
Connect Biopharma Quarterly Net Working Capital |
|
Connect Biopharma Stock Technical Analysis
Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Connect Biopharma Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Connect Biopharma Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Connect Biopharma November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Connect Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Connect Biopharma shares will generate the highest return on investment. By undertsting and applying Connect Biopharma stock market strength indicators, traders can identify Connect Biopharma Holdings entry and exit signals to maximize returns
Connect Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Connect Biopharma's price direction in advance. Along with the technical and fundamental analysis of Connect Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Connect to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.033 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.91) | |||
| Sortino Ratio | 0.0163 | |||
| Treynor Ratio | 0.1045 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Connect Stock analysis
When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |